CVS Health
CVS
1,846 hedge funds and large institutions have $64B invested in CVS Health in 2024 Q3 according to their latest regulatory filings, with 157 funds opening new positions, 490 increasing their positions, 1,014 reducing their positions, and 208 closing their positions.
22% more call options, than puts
Call options by funds: $1.77B | Put options by funds: $1.45B
4% more funds holding in top 10
Funds holding in top 10: 27 → 28 (+1)
0.87% less ownership
Funds ownership: 81.71% → 80.83% (-0.87%)
10% less capital inflows, than outflows
Capital inflows: $4.47B | Capital outflows: $4.95B
4% less funds holding
Funds holding: 1,917 → 1,846 (-71)
25% less first-time investments, than exits
New positions opened: 157 | Existing positions closed: 208
52% less repeat investments, than reductions
Existing positions increased: 490 | Existing positions reduced: 1,014
Top Buyers
| Rank | Fund | Capital Flow |
|---|---|---|
| 1 |
Capital International Investors
Los Angeles,
California
|
+$275M |
| 2 |
Millennium Management
New York
|
+$269M |
| 3 |
BlackRock
New York
|
+$257M |
| 4 |
Amundi
Paris,
France
|
+$199M |
| 5 |
Two Sigma Investments
New York
|
+$182M |
Top Sellers
| Rank | Fund | Capital Flow |
|---|---|---|
| 1 |
Capital Research Global Investors
Los Angeles,
California
|
-$1.74B |
| 2 |
Capital World Investors
Los Angeles,
California
|
-$455M |
| 3 |
Holocene Advisors
New York
|
-$162M |
| 4 |
Canoe Financial
Calgary,
Alberta, Canada
|
-$109M |
| 5 |
KBC Group
Brussels,
Belgium
|
-$73M |
CVS Hedge Fund Activity: Q3 2024 in Review
1,846 of the 6,987 institutional investors tracked by Wall St. Rank reported a position in CVS Health (CVS) for Q3 2024, worth a combined $64B — up 5.5% from $60.6B a quarter earlier.
Sellers outnumbered buyers: 208 funds closed out of CVS and 157 opened new positions — a net loss of 51 holders — while 1,014 trimmed existing stakes and 490 added.
The largest buyer was Capital International Investors, adding an estimated $275M. The largest seller was Capital Research Global Investors, cutting an estimated $1.74B.
- 1,846 institutional investors held CVS Health (CVS) as of Q3 2024, down from 1,917 in Q2 2024.
- Funds reported $64B of CVS Health stock for Q3 2024, up 5.5% quarter-over-quarter.
- 157 funds opened new CVS Health positions in Q3 2024 and 208 closed out, a net change of -51 holders.
- The largest CVS Health buyer in Q3 2024 was Capital International Investors, an estimated $275M added.
- The largest CVS Health seller in Q3 2024 was Capital Research Global Investors, an estimated $1.74B sold.
Based on aggregated 13F filings for Q3 2024.